Chris Howerton

Stock Analyst at Jefferies

(0.63)
# 2277
Out of 5,332 analysts
100
Total ratings
38.10%
Success rate
-8.40%
Average return
45 Stocks
Name Action PT Current % Upside Ratings Updated
ARDX Ardelyx
Maintains: Buy
11 8
3.69 116.8% 5 Jan 2, 2025
GPCR Structure Therapeuti...
Maintains: Strong Buy
50 79
26.55 197.55% 2 Sep 29, 2023
PNT POINT Biopharma Glob...
Assumes: Strong Buy
12 14
n/a n/a 3 Jul 20, 2023
MIST Milestone Pharmaceut...
Downgrades: Hold
8 4
1.28 212.5% 4 Jun 20, 2023
VERU Veru
Upgrades: Hold
1
0.5 100% 3 Jun 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
25
n/a n/a 4 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
320 352
1.51 23211.26% 2 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
1 1
n/a n/a 3 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
720
4.53 15794.04% 2 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
1
1.25 -60% 2 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
35 10
10.11 -1.09% 1 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
8 2
2.05 -2.44% 3 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
2 1
n/a n/a 3 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
n/a n/a 1 Dec 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
7 11
9.49 15.91% 3 Nov 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
30 20
n/a n/a 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
70 40
17.96 122.72% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
57 61
33.58 81.66% 3 Oct 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
92 90
111.15 -19.03% 3 Sep 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
870 510
n/a n/a 2 Apr 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
180 183
n/a n/a 2 Mar 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
23 2
n/a n/a 2 Mar 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
24 12
4.38 173.97% 5 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
100
n/a n/a 3 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
101 126
1.14 10952.63% 1 Dec 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
0.98 1940.82% 1 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
66
18.94 248.47% 4 Sep 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
n/a n/a 1 Aug 24, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
4.51 387.8% 1 Aug 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
1.4 1400% 1 Aug 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
0.92 2291.3% 1 May 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
n/a n/a 1 Apr 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
1.28 1696.88% 1 Apr 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
220 360
n/a n/a 3 Apr 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
40 21
14.8 41.89% 4 Apr 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
7 5
n/a n/a 2 Mar 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
6
n/a n/a 3 Dec 10, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
55 88
n/a n/a 2 Sep 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
n/a n/a 1 Aug 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
19
n/a n/a 1 Aug 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
80 580
8.29 6896.38% 2 Aug 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
63 60
1.38 4247.83% 1 Aug 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
16
70.28 -77.23% 2 Aug 5, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
27
43.17 -37.46% 1 Jul 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
0.11 21718.18% 1 May 26, 2020